Non-alcoholic Steatohepatitis
📧 Sign up to get email alerts when something new happens for Non-alcoholic Steatohepatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-10Clinical Trial Update: Comparative Study Between Obeticholic Acid Versus Vitamin E in Patients with Non-alcoholic Steatohepatitis [Phase 2]
An ongoing Phase 2 clinical trial comparing obeticholic acid versus vitamin E for non-alcoholic steatohepatitis is currently not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-12-19Clinical Trial Update: Study of TVB-2640 in Subjects With Non-Alcoholic Steatohepatitis (NASH) [Phase 2]
Phase 2 study of TVB-2640 in MASLD/MASH/NASH has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-12-03Clinical Trial Update: A Study to Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3) [Phase 2]
Results from a Phase 2 trial evaluating the safety and efficacy of survodutide (BI456906) in adults with non-alcoholic steatohepatitis and f…
-
CLINICAL_TRIALS trial_result · 2024-11-14Clinical Trial Update: NASH Patient's Itinerary: Comparison of Strategies for Screening, Referring and Management of Diabetic Patients [NA]
A completed clinical trial comparing strategies for screening, referral, and management of diabetic patients with non-alcoholic fatty liver …
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Soluble Fibre Supplementation in NAFLD [Phase 2]
A Phase 2 clinical trial is evaluating soluble fibre supplementation for non-alcoholic fatty liver disease and related conditions and is cur…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Evaluating the Efficacy and Safety of Roflumilast in Patients with NASH [Phase 2]
Phase 2 trial evaluates the efficacy and safety of roflumilast in patients with non-alcoholic steatohepatitis (NASH); study completed.
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Saroglitazar Magnesium in the Treatment of Non-Alcoholic Steatohepatitis [Phase 2]
Phase 2 clinical trial evaluating saroglitazar magnesium for non-alcoholic steatohepatitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Combined Active Treatment in Type 2 Diabetes with NASH [Phase 4]
A Phase 4 clinical trial evaluating a combined active treatment approach for type 2 diabetes mellitus with non-alcoholic steatohepatitis (NA…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Efficacy and Safety of Dapagliflozin in Patients with Non-alcoholic Steatohepatitis [Phase 2]
Phase 2 trial evaluating the efficacy and safety of dapagliflozin in patients with non-alcoholic steatohepatitis has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-22Clinical Trial Update: Ultrasound and Attenuation Imaging
Clinical trial update reporting a completed study on ultrasound and attenuation imaging for assessing fatty liver disease, including non-alc…
-
CLINICAL_TRIALS trial_result · 2024-07-09Clinical Trial Update: Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus [Phase 2]
A Phase 2 placebo-controlled study to evaluate the safety and efficacy of lanifibranor alone and in combination with empagliflozin in patien…
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: FTIH of ECC4703 in Healthy Volunteers [EARLY_Phase 1]
The document reports the completion of first-time-in-human Phase 1 testing of ECC4703 in healthy volunteers as part of development for Non-a…
-
CLINICAL_TRIALS trial_result · 2024-05-29Clinical Trial Update: A Research Study on How Semaglutide Works in People With Fatty Liver Disease and Liver Damage [Phase 2]
Phase 2 trial evaluating semaglutide in non-alcoholic steatohepatitis has completed, with results posted in May 2024.
-
CLINICAL_TRIALS trial_result · 2024-04-16Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Participants With Non-Alcoholic Steatohepatitis [Phase 2]
Phase 2 study evaluating BFKB8488A vs placebo in non-alcoholic steatohepatitis was terminated with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-04-05Clinical Trial Update: Effect of Dipeptidyl Peptidase- 4 Inhibitors on Non-Alcoholic Steatohepatitis and Type 1 Diabetes [Phase 3]
Phase 3 trial assessing Dipeptidyl Peptidase-4 inhibitors for Type 1 diabetes and non-alcoholic steatohepatitis (NASH) has completed.
-
CLINICAL_TRIALS trial_result · 2024-02-21Clinical Trial Update: A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of HEC96719 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis [Phase 2]
Phase 2 trial assessing safety, tolerability, efficacy, and pharmacokinetics of HEC96719 in non-cirrhotic non-alcoholic steatohepatitis has …
-
CLINICAL_TRIALS trial_result · 2024-01-12Clinical Trial Update: Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 Analogue [Phase 1, Phase 2]
Clinical trial update investigating a GLP-1/GIP analogue for non-alcoholic fatty liver disease in patients with type 2 diabetes; phase 1/2 w…
-
CLINICAL_TRIALS trial_result · 2023-08-08Clinical Trial Update: Efficacy and Safety of Berberine in Non-alcoholic Steatohepatitis [Phase 4]
Phase 4 clinical trial update evaluating the efficacy and safety of berberine in non-alcoholic steatohepatitis.
-
CLINICAL_TRIALS trial_result · 2023-07-12Clinical Trial Update: the Efficacy and Safety of Diosmin on Non-diabetic Patients With Non-alcoholic Steatohepatitis. [Phase 3]
Phase 3 clinical trial updating the efficacy and safety of diosmin in non-diabetic patients with non-alcoholic steatohepatitis.
-
CLINICAL_TRIALS trial_result · 2023-05-25Clinical Trial Update: Vitamin E and DHA-EE on NAFLD - Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial (PUVENAFLD) [Phase 2]
A Phase 2 randomized, double-blind study evaluating vitamin E and DHA-EE for non-alcoholic fatty liver disease, completed with results poste…
-
CLINICAL_TRIALS trial_result · 2023-05-19Clinical Trial Update: A Randomized, Double-blind Study to Assess the Safety and Efficacy of EDP-305 in Subjects With Liver-biopsy Proven NASH [Phase 2]
Phase 2 randomized trial assessing safety and efficacy of EDP-305 in non-alcoholic steatohepatitis (NASH) has been terminated; results poste…
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Efficacy of EYP001a in Patients With Nonalcoholic Steatohepatitis (NASH) [Phase 2]
Phase 2 clinical trial of EYP001a in nonalcoholic steatohepatitis completed; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-04-07Clinical Trial Update: Misoprostol for NASH [Phase 2]
Phase 2 clinical trial evaluating misoprostol for non-alcoholic steatohepatitis (NASH) has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-15Clinical Trial Update: Open-Label Study To Evaluate MN-001 on HDL & Triglyceride in NASH & NAFLD Subjects [Phase 2]
Phase 2 open-label trial evaluating MN-001 on HDL and triglycerides in subjects with NASH/NAFLD completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-11-04Clinical Trial Update: Comparative Clinical Study Between Empagliflozin Versus Pioglitazone in Non-diabetic Patients With Non-alcoholic Steatohepatitis [Phase 3]
Phase 3 comparative trial of empagliflozin versus pioglitazone in non-diabetic patients with non-alcoholic steatohepatitis (NASH) is in an u…